FOR RESEARCH PURPOSES ONLY • 21+ ACCESS
PRIMARY CATALOGWholesale Kits · 10 vials eachShop kits →

SPECIALTY / DIRECT CATALOG PRICING

PNC-27

PNC-27 is a 32-residue chimeric peptide containing a p53-derived HDM2-binding segment joined to a membrane-residency/cell-penetrating sequence.

Format
Lyophilized research vial
Listed formats
1
Available now
0
Catalog class
Specialty

Choose a listed format

Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.

TECHNICAL OVERVIEW

Identity first, claims kept in scope.

PNC-27 is a 32-residue chimeric peptide containing a p53-derived HDM2-binding segment joined to a membrane-residency/cell-penetrating sequence.

The specialty classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.

SPECIFICATIONS

Material class
Specialty
Physical format
Lyophilized vial
Research status
Research purposes only
Commerce status
Contact for current availability

PLAIN-LANGUAGE RESEARCH SNAPSHOT

What researchers have actually studied.

PNC-27 is a 32-residue chimeric peptide containing a p53-derived HDM2-binding segment joined to a membrane-residency/cell-penetrating sequence.

Research covered
Published studies examined PNC-27 binding, membrane-pore formation, and cell death in cancer-cell lines, including pancreatic and leukemia models; additional work used AML animal models. These are mechanistic preclinical experiments.
Important limit
No human clinical evidence was identified. Cell-line and animal findings do not establish clinical activity, safety, or the identity of this catalog's 5 mg material.
Catalog availability does not imply evidence strength, product equivalence, safety, efficacy, or a suggested combination. No dosage or use recommendation is provided.

FACTUAL FAQ

PNC-27 catalog questions

What formats are currently listed?

5 mg. Current price and stock state appear above.

What did researchers study?

Published studies examined PNC-27 binding, membrane-pore formation, and cell death in cancer-cell lines, including pancreatic and leukemia models; additional work used AML animal models. These are mechanistic preclinical experiments.

What is the most important evidence limit?

No human clinical evidence was identified. Cell-line and animal findings do not establish clinical activity, safety, or the identity of this catalog's 5 mg material.

How should this listing be interpreted?

It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.

Where can I review related scientific references?

Use the PSC research library to locate general and compound-related source material. Open related research references →

DIRECT CATALOG SUPPORT

Looking for something specific?

Contact PSC before ordering when you need help locating a research compound, confirming current stock or product identity, understanding Bitcoin checkout, or requesting bulk pricing.

One support address. Include the exact catalog name and desired quantity for the fastest response.

Email catalog support↗